Literature DB >> 24855641

Structural basis of G protein-coupled receptor-Gi protein interaction: formation of the cannabinoid CB2 receptor-Gi protein complex.

Jagjeet S Mnpotra1, Zhuanhong Qiao2, Jian Cai2, Diane L Lynch1, Alan Grossfield3, Nicholas Leioatts3, Dow P Hurst1, Michael C Pitman4, Zhao-Hui Song5, Patricia H Reggio6.   

Abstract

In this study, we applied a comprehensive G protein-coupled receptor-Gαi protein chemical cross-linking strategy to map the cannabinoid receptor subtype 2 (CB2)-Gαi interface and then used molecular dynamics simulations to explore the dynamics of complex formation. Three cross-link sites were identified using LC-MS/MS and electrospray ionization-MS/MS as follows: 1) a sulfhydryl cross-link between C3.53(134) in TMH3 and the Gαi C-terminal i-3 residue Cys-351; 2) a lysine cross-link between K6.35(245) in TMH6 and the Gαi C-terminal i-5 residue, Lys-349; and 3) a lysine cross-link between K5.64(215) in TMH5 and the Gαi α4β6 loop residue, Lys-317. To investigate the dynamics and nature of the conformational changes involved in CB2·Gi complex formation, we carried out microsecond-time scale molecular dynamics simulations of the CB2 R*·Gαi1β1γ2 complex embedded in a 1-palmitoyl-2-oleoyl-phosphatidylcholine bilayer, using cross-linking information as validation. Our results show that although molecular dynamics simulations started with the G protein orientation in the β2-AR*·Gαsβ1γ2 complex crystal structure, the Gαi1β1γ2 protein reoriented itself within 300 ns. Two major changes occurred as follows. 1) The Gαi1 α5 helix tilt changed due to the outward movement of TMH5 in CB2 R*. 2) A 25° clockwise rotation of Gαi1β1γ2 underneath CB2 R* occurred, with rotation ceasing when Pro-139 (IC-2 loop) anchors in a hydrophobic pocket on Gαi1 (Val-34, Leu-194, Phe-196, Phe-336, Thr-340, Ile-343, and Ile-344). In this complex, all three experimentally identified cross-links can occur. These findings should be relevant for other class A G protein-coupled receptors that couple to Gi proteins.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cannabinoid Receptor; G Protein-coupled Receptor (GPCR); Mass Spectrometry (MS); Molecular Dynamics; Signal Transduction

Mesh:

Substances:

Year:  2014        PMID: 24855641      PMCID: PMC4106340          DOI: 10.1074/jbc.M113.539916

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: use of a photoactivatable reagent.

Authors:  K Cai; Y Itoh; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  CHARMM-GUI: a web-based graphical user interface for CHARMM.

Authors:  Sunhwan Jo; Taehoon Kim; Vidyashankara G Iyer; Wonpil Im
Journal:  J Comput Chem       Date:  2008-08       Impact factor: 3.376

3.  Light-activated rhodopsin induces structural binding motif in G protein alpha subunit.

Authors:  O G Kisselev; J Kao; J W Ponder; Y C Fann; N Gautam; G R Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Receptor and betagamma binding sites in the alpha subunit of the retinal G protein transducin.

Authors:  R Onrust; P Herzmark; P Chi; P D Garcia; O Lichtarge; C Kingsley; H R Bourne
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

5.  The 2.0 A crystal structure of a heterotrimeric G protein.

Authors:  D G Lambright; J Sondek; A Bohm; N P Skiba; H E Hamm; P B Sigler
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

6.  A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.

Authors:  Dow P Hurst; Alan Grossfield; Diane L Lynch; Scott Feller; Tod D Romo; Klaus Gawrisch; Michael C Pitman; Patricia H Reggio
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

7.  Effects of D3.49A, R3.50A, and A6.34E mutations on ligand binding and activation of the cannabinoid-2 (CB2) receptor.

Authors:  Wenke Feng; Z H Song
Journal:  Biochem Pharmacol       Date:  2003-04-01       Impact factor: 5.858

8.  Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit.

Authors:  H E Hamm; D Deretic; A Arendt; P A Hargrave; B Koenig; K P Hofmann
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain.

Authors:  Ildiko Racz; Xavier Nadal; Judith Alferink; Josep E Baños; Jennifer Rehnelt; Miquel Martín; Belén Pintado; Alfonso Gutierrez-Adan; Elena Sanguino; Jorge Manzanares; Andreas Zimmer; Rafael Maldonado
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

View more
  17 in total

1.  G protein-coupled receptor kinases: Past, present and future.

Authors:  Konstantin E Komolov; Jeffrey L Benovic
Journal:  Cell Signal       Date:  2017-07-12       Impact factor: 4.315

Review 2.  Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Authors:  Robert P Picone; Debra A Kendall
Journal:  Mol Endocrinol       Date:  2015-04-13

3.  Methods for the Development of In Silico GPCR Models.

Authors:  Paula Morales; Dow P Hurst; Patricia H Reggio
Journal:  Methods Enzymol       Date:  2017-07-14       Impact factor: 1.600

4.  Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex.

Authors:  Changrui Xing; Youwen Zhuang; Ting-Hai Xu; Zhiwei Feng; X Edward Zhou; Maozi Chen; Lei Wang; Xing Meng; Ying Xue; Junmei Wang; Heng Liu; Terence Francis McGuire; Gongpu Zhao; Karsten Melcher; Cheng Zhang; H Eric Xu; Xiang-Qun Xie
Journal:  Cell       Date:  2020-01-30       Impact factor: 41.582

5.  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Authors:  María Gómez-Cañas; Gemma Navarro; Paula Morales; Dow P Hurst; Francisco J Carrillo-Salinas; Laura Lagartera; Ruth Pazos; Pilar Goya; Patricia H Reggio; Carmen Guaza; Rafael Franco; Javier Fernández-Ruiz; Nadine Jagerovic
Journal:  J Med Chem       Date:  2016-07-06       Impact factor: 7.446

Review 6.  Mechanistic insights into GPCR-G protein interactions.

Authors:  Jacob P Mahoney; Roger K Sunahara
Journal:  Curr Opin Struct Biol       Date:  2016-11-18       Impact factor: 6.809

7.  Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.

Authors:  A F Marmolejo-Valencia; K Martínez-Mayorga
Journal:  J Comput Aided Mol Des       Date:  2017-03-31       Impact factor: 3.686

8.  Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.

Authors:  Kaavya Krishna Kumar; Moran Shalev-Benami; Michael J Robertson; Hongli Hu; Samuel D Banister; Scott A Hollingsworth; Naomi R Latorraca; Hideaki E Kato; Daniel Hilger; Shoji Maeda; William I Weis; David L Farrens; Ron O Dror; Sanjay V Malhotra; Brian K Kobilka; Georgios Skiniotis
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

9.  Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.

Authors:  Jianping Hu; Zhiwei Feng; Shifan Ma; Yu Zhang; Qin Tong; Mohammed Hamed Alqarni; Xiaojun Gou; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2016-05-26       Impact factor: 4.956

10.  Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation.

Authors:  Zhiwei Feng; Larry V Pearce; Yu Zhang; Changrui Xing; Brienna K A Herold; Shifan Ma; Ziheng Hu; Noe A Turcios; Peng Yang; Qin Tong; Anna K McCall; Peter M Blumberg; Xiang-Qun Xie
Journal:  AAPS J       Date:  2016-03-21       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.